Ellen W. Leen‐Feldner Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Professor / Vice Chair

University of Arkansas at Fayetteville

faculty

36 h-index 114 pubs 3,487 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Ellen W. Leen‐Feldner, Professor and Vice Chair at the University of Arkansas at Fayetteville, investigates the effects of various substances, particularly cannabidiol (CBD), on human anxiety, withdrawal symptoms, and emotional states. Her recent work includes a double-blind, randomized placebo-controlled trial examining CBD's impact on worry and anxiety in individuals with high trait anxiety, as well as a study on the use patterns and perceived effects of hexahydrocannabinol cannabis products. Leen‐Feldner has also explored the effects of acute sleep deprivation on affect and avoidance behaviors. Her research often employs rigorous experimental designs, including randomized controlled trials and double-blind placebo controls, to assess the efficacy and practical considerations of pharmacological interventions for psychological conditions.

Her scholarship metrics include an h-index of 36, with 114 total publications and 3,487 total citations, designating her as a highly cited researcher. Leen‐Feldner actively collaborates with colleagues at the University of Arkansas at Fayetteville, including L. Riley Gournay, Matthew T. Feldner, Morgan A. Hill, and Morgan L. Ferretti, with whom she has co-authored multiple publications. She maintains an active lab website, suggesting ongoing research and potential opportunities for engagement.

Metrics

  • h-index: 36
  • Publications: 114
  • Citations: 3,487

Selected Publications

  • Hypothalamic-pituitary-adrenal (HPA) axis stress response to a laboratory-based 10 % CO2 challenge in healthy adults (2025) DOI
  • The effects of acute versus repeated cannabidiol administration on trauma‐relevant emotional reactivity: A double‐blind, randomized, placebo‐controlled trial (2024) DOI
  • Cannabidiol (CBD) Products: Use Patterns and Perceptions Within a Sample of Anxious Users (2024) DOI
  • 0108 Sleep Deprivation Impairs the Ability to Reappraise Negative Situations (2024) DOI
  • A Survey Study of Individuals Using Hexahydrocannabinol Cannabis Products: Use Patterns and Perceived Effects (2023) DOI
  • The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial (2023) DOI
  • Investigating the effect of hormonal contraceptive use on salivary cortisol response to a CO2 challenge (2023) DOI
  • Does a laboratory-based CO2 challenge induce a hypothalamic-pituitary-adrenal (HPA) axis stress response in healthy adults? (2023) DOI
  • Cannabidiol Reduces Nicotine Withdrawal Severity and State Anxiety During an Acute E-cigarette Abstinence Period: A Novel, Open-Label Study (2023) DOI
  • A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge (2022) DOI
  • A laboratory-based examination of a standardized sexual assault script (2022) DOI
  • An experimental test of the effects of acute sleep deprivation on affect and avoidance (2022) DOI
  • Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey (2022) DOI
  • Greater adolescent tiredness is related to more emotional arousal during a hyperventilation task: An area under the curve approach (2021) DOI
  • Practical considerations for testing the effects of cannabidiol on human anxiety (2021) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics